DHAKA,BANGLADESH––Zenex Animal Heal the unveiled a novel probioticstrain, Bacillus siamen sis ZMT02(BSZMT02),there volutionary gut health solution for chicken that improves production indices,while allowing farmers to withdraw gut-acting antibiotics and AGPs.The break through discovery of the novels train was possible through years of research atthe Department of Cell, Molecular Biology and Microbiome The rapeutics, Zydus Research Centre(ZRC), India. Globally, for the first time ever, the discovery pathway involve disolation,strategic screening and strain level characterization of beneficial microflora from healthy chicken gastrointestinaltract. Probiotic candidate sidentified during the study were rigorouslye valuated for safety, performance, stability, anti-inflammatory and anti-microbial parameters.
Then ovelstrain,BSZMT02,embodiesallthe necessary characteristics of anideal probiotic for chicken enabling antibiotic/AGP free farming and will fuel the probiotic products viz, Improval™ BFS and Improval™ MS.
Scientific presentations were made at Le Meridian, Dhaka, Bangladesh amidstof the farming community and poultry professionals by the research lead in support with local partner A.R.Animal Health, Bangladesh.The events were attended by more than 60 eminent stakeholders in the sector involving,layer and breeder farmers,in tegrators, feedmillers’ consultants and veterinary doctors.
“Anti-microbial resistance(AMR) is a global threat and poultry health sector is under tremendous pressure for restriction on critically important antibiotics and AGPs.”said Dr Arun Atrey, MD & CEO, Zenex AH.“Builtup on years of innovation,BSZMT02 is unlike any thing available before in the category. It unlock sincredible future for the poultry farming community towards sustainability without antibiotics.“
“We took arationale approach while devising the discovery path way of isolating probiotic candidates from chicken GIT and it has been an exciting journey and truly exemplary.”said Dr. Susim Ray, Head–Technical & promotion (Poultry), Zenex Animal Health, India.“We always believed that the best probiotic strain can only be obtained from it stargethost, the chicken in our case and it is just important to set the right criteria of selection.”Talking about the pipelines, Dr Raysaid,“Although full genetic characterization of the isolated strain including BSZMT02 is completed, we will continue our endeav our sin further characterization of regulatory and functional proteins of the isolates with the goal of improving upon present solution.”
“Today is the day we have been looking forward to sincelast four years and we are thrilled to introduce the unfailing gut health solution.”said Dr Rupesh Rane, Head of International Business, Zenex AH.“Controlled field trials throughout India have consistently shown BSZMT02 to significantly improve production parameters without gut-acting antibiotics and AGP sin chicken vis- à-viscontrol and it is surely going to be a bench mark in the category. ”Describing initiatives of Zenex AH in response to AMR threats, Dr Rane said, “We are relentlessly working hard and committed to build strong pipeline salternative to antibiotics/AGPs and BSZMT02, the novel probiotic strain,is just the stepping stone. How ever, we look forward to the necessary support of Poultry consultants, feed millers, poultry professionals, and farmers in making the initiatives counts.”